NAMS
NewAmsterdam Pharma Company N.V. Ordinary Shares
$31.25
0.92%
+0.29
Notify me if price changes either direction
Buy NAMS stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
3.6B
Enterprise value
2.8B
Trailing PE
-18.226744407831
Forward PE
-22.153557
PEG Ratio
-22.153557
Enterprise to EBITDA
-12.508
Enterprise to revenue
125.322
Price to book MRQ
5.0318046
Price to sales TTM
153.58669
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2025-12-31
Revenue (TTM)
22.5M
EBITDA
-225463008
Diluted EPS TTM
-1.72
Total Cash (MRQ)
636.2M
Current ratio (MRQ)
7.876
Operating Cash Flow (TTM)
-147783008
NAMS trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
March 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
